Novartis AG Current Trade Receivables
Novartis AG (NVSEF) had Current Trade Receivables of $8.94 billion as of 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Notes › Receivables
ifrs-full:CurrentTradeReceivables · last filed 2026-02-04
- 2025-12-31: Current Trade Receivables $8.94B.
- 2025-06-30: Current Trade Receivables $9.06B.
- 2024-12-31: Current Trade Receivables $7.42B.
- 2024-06-30: Current Trade Receivables $8.23B.
| Period end | Current Trade Receivables |
|---|---|
| 2025-12-31 | $8.94B 20-F · filed 2026-02-04 |
| 2025-06-30 | $9.06B 6-K · filed 2025-07-17 |
| 2024-12-31 | $7.42B 20-F · filed 2026-02-04 |
| 2024-06-30 | $8.23B 6-K · filed 2024-07-18 |
| 2023-12-31 | $7.11B 20-F · filed 2025-01-31 |
| 2023-06-30 | $9.20B 6-K · filed 2023-07-18 |
| 2022-12-31 | $8.07B 20-F · filed 2024-01-31 |
| 2022-06-30 | $8.64B 6-K · filed 2022-07-19 |
| 2021-12-31 | $8.01B 20-F/A · filed 2023-05-15 |
| 2021-06-30 | $8.40B 6-K · filed 2021-07-21 |
| 2020-12-31 | $8.22B 20-F · filed 2022-02-02 |
| 2020-06-30 | $7.64B 6-K · filed 2020-07-21 |
| 2019-12-31 | $8.30B 20-F · filed 2021-01-26 |
| 2019-06-30 | $7.97B 6-K · filed 2019-07-18 |
| 2018-12-31 | $8.73B 20-F · filed 2020-01-29 |
| 2018-06-30 | $8.80B 6-K · filed 2018-07-18 |
| 2017-12-31 | $8.60B 20-F · filed 2019-01-30 |
| 2016-12-31 | $8.20B 6-K · filed 2018-01-24 |